新希望(000876.SZ):半年度預盈6.8億元-7.8億元 同比扭虧
格隆匯7月14日丨新希望(000876.SZ)公佈2025年半年度業績預吿,1-6月公司實現歸屬於上市公司股東的淨利潤盈利68,000萬元–78,000萬元,同比扭虧為盈;扣除非經常性損益後的淨利潤盈利62,700萬元–72,700萬元;基本每股收益盈利0.14元/股–0.16元/股。
公司在生豬養殖業務上,於2024年完成了多條場線的防疫改造,同時狠抓生產管理與冬春季防疫工作,使上半年各項生產指標持續改善,養殖成本實現同環比雙降,在上半年平均豬價同比降低的情況下,生豬養殖業務仍然實現同比扭虧。此外,公司飼料業務亦持續優化,在上半年亦取得了量利同增。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.